|Articles|November 14, 2016
PAREXEL Launches IDMP-Focused Solution
PAREXEL has launched an Identification of Medicinal Products (IDMP)-focused solution, Liquent InSight, for biopharma companies.
Advertisement
PAREXEL has launched an Identification of Medicinal Products (IDMP)-focused solution, Liquent InSight, for biopharma companies. This solution will allow these companies to collect and submit data while meeting the International Organization Standardization (ISO) requirements for increased transparency.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
2
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
3
Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership
4
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
